The role of somatostatin analogs in the management of prostate cancer

J Endocrinol Invest. 2003;26(8 Suppl):120-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents, Hormonal / pharmacology
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Male
  • Octreotide / pharmacology
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / metabolism
  • RNA, Messenger / analysis
  • Receptors, Somatostatin / metabolism
  • Somatostatin / analogs & derivatives*
  • Somatostatin / genetics
  • Somatostatin / pharmacology
  • Somatostatin / therapeutic use
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents, Hormonal
  • RNA, Messenger
  • Receptors, Somatostatin
  • Somatostatin
  • Octreotide